Global Addictions Therapeutics Market Research Report 2023
Global Addictions Therapeutics Market Overview:
Global Addictions Therapeutics Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Addictions Therapeutics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Addictions Therapeutics Market
The Addictions Therapeutics Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Addictions Therapeutics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Addictions Therapeutics Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Addictions Therapeutics Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Addictions Therapeutics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Addictions Therapeutics Market Segmentation
Global Addictions Therapeutics Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Addictions Therapeutics market has been segmented into:
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
By Application, Addictions Therapeutics market has been segmented into:
Public
Private
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Addictions Therapeutics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Addictions Therapeutics market.
Top Key Players Covered in Addictions Therapeutics market are:
Alkermes Plc
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
Opiant Pharmaceuticals Inc.
Indivior Plc
Novartis AG
Novo Nordisk AS
Amneal Pharmaceuticals Inc.
Pfizer Inc.
Mylan NV
Objective to buy this Report:
1. Addictions Therapeutics analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Addictions Therapeutics market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Addictions Therapeutics Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Addictions Therapeutics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Addictions Therapeutics Market
The Addictions Therapeutics Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Addictions Therapeutics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Addictions Therapeutics Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Addictions Therapeutics Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Addictions Therapeutics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Addictions Therapeutics Market Segmentation
Global Addictions Therapeutics Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Addictions Therapeutics market has been segmented into:
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
By Application, Addictions Therapeutics market has been segmented into:
Public
Private
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Addictions Therapeutics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Addictions Therapeutics market.
Top Key Players Covered in Addictions Therapeutics market are:
Alkermes Plc
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
Opiant Pharmaceuticals Inc.
Indivior Plc
Novartis AG
Novo Nordisk AS
Amneal Pharmaceuticals Inc.
Pfizer Inc.
Mylan NV
Objective to buy this Report:
1. Addictions Therapeutics analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Addictions Therapeutics market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: ADDICTIONS THERAPEUTICS MARKET BY TYPE
5.1 Addictions Therapeutics Market Overview Snapshot and Growth Engine
5.2 Addictions Therapeutics Market Overview
5.3 Alcohol Addiction Therapeutics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Alcohol Addiction Therapeutics: Geographic Segmentation
5.4 Tobacco Addiction Therapeutics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Tobacco Addiction Therapeutics: Geographic Segmentation
5.5 Drug Addiction Therapeutics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Drug Addiction Therapeutics: Geographic Segmentation
CHAPTER 6: ADDICTIONS THERAPEUTICS MARKET BY APPLICATION
6.1 Addictions Therapeutics Market Overview Snapshot and Growth Engine
6.2 Addictions Therapeutics Market Overview
6.3 Public
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Public: Geographic Segmentation
6.4 Private
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Private: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Addictions Therapeutics Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Addictions Therapeutics Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Addictions Therapeutics Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ALKERMES PLC
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 JOHNSON & JOHNSON SERVICES INC.
7.4 TEVA PHARMACEUTICAL INDUSTRIES LTD.
7.5 OPIANT PHARMACEUTICALS INC.
7.6 INDIVIOR PLC
7.7 NOVARTIS AG
7.8 NOVO NORDISK AS
7.9 AMNEAL PHARMACEUTICALS INC.
7.10 PFIZER INC.
7.11 MYLAN NV
CHAPTER 8: GLOBAL ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Alcohol Addiction Therapeutics
8.2.2 Tobacco Addiction Therapeutics
8.2.3 Drug Addiction Therapeutics
8.3 Historic and Forecasted Market Size By Application
8.3.1 Public
8.3.2 Private
CHAPTER 9: NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Alcohol Addiction Therapeutics
9.4.2 Tobacco Addiction Therapeutics
9.4.3 Drug Addiction Therapeutics
9.5 Historic and Forecasted Market Size By Application
9.5.1 Public
9.5.2 Private
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Alcohol Addiction Therapeutics
10.4.2 Tobacco Addiction Therapeutics
10.4.3 Drug Addiction Therapeutics
10.5 Historic and Forecasted Market Size By Application
10.5.1 Public
10.5.2 Private
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Alcohol Addiction Therapeutics
11.4.2 Tobacco Addiction Therapeutics
11.4.3 Drug Addiction Therapeutics
11.5 Historic and Forecasted Market Size By Application
11.5.1 Public
11.5.2 Private
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Alcohol Addiction Therapeutics
12.4.2 Tobacco Addiction Therapeutics
12.4.3 Drug Addiction Therapeutics
12.5 Historic and Forecasted Market Size By Application
12.5.1 Public
12.5.2 Private
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Alcohol Addiction Therapeutics
13.4.2 Tobacco Addiction Therapeutics
13.4.3 Drug Addiction Therapeutics
13.5 Historic and Forecasted Market Size By Application
13.5.1 Public
13.5.2 Private
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: ADDICTIONS THERAPEUTICS MARKET BY TYPE
5.1 Addictions Therapeutics Market Overview Snapshot and Growth Engine
5.2 Addictions Therapeutics Market Overview
5.3 Alcohol Addiction Therapeutics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Alcohol Addiction Therapeutics: Geographic Segmentation
5.4 Tobacco Addiction Therapeutics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Tobacco Addiction Therapeutics: Geographic Segmentation
5.5 Drug Addiction Therapeutics
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Drug Addiction Therapeutics: Geographic Segmentation
CHAPTER 6: ADDICTIONS THERAPEUTICS MARKET BY APPLICATION
6.1 Addictions Therapeutics Market Overview Snapshot and Growth Engine
6.2 Addictions Therapeutics Market Overview
6.3 Public
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Public: Geographic Segmentation
6.4 Private
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Private: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Addictions Therapeutics Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Addictions Therapeutics Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Addictions Therapeutics Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ALKERMES PLC
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 JOHNSON & JOHNSON SERVICES INC.
7.4 TEVA PHARMACEUTICAL INDUSTRIES LTD.
7.5 OPIANT PHARMACEUTICALS INC.
7.6 INDIVIOR PLC
7.7 NOVARTIS AG
7.8 NOVO NORDISK AS
7.9 AMNEAL PHARMACEUTICALS INC.
7.10 PFIZER INC.
7.11 MYLAN NV
CHAPTER 8: GLOBAL ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Alcohol Addiction Therapeutics
8.2.2 Tobacco Addiction Therapeutics
8.2.3 Drug Addiction Therapeutics
8.3 Historic and Forecasted Market Size By Application
8.3.1 Public
8.3.2 Private
CHAPTER 9: NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Alcohol Addiction Therapeutics
9.4.2 Tobacco Addiction Therapeutics
9.4.3 Drug Addiction Therapeutics
9.5 Historic and Forecasted Market Size By Application
9.5.1 Public
9.5.2 Private
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Alcohol Addiction Therapeutics
10.4.2 Tobacco Addiction Therapeutics
10.4.3 Drug Addiction Therapeutics
10.5 Historic and Forecasted Market Size By Application
10.5.1 Public
10.5.2 Private
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Alcohol Addiction Therapeutics
11.4.2 Tobacco Addiction Therapeutics
11.4.3 Drug Addiction Therapeutics
11.5 Historic and Forecasted Market Size By Application
11.5.1 Public
11.5.2 Private
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Alcohol Addiction Therapeutics
12.4.2 Tobacco Addiction Therapeutics
12.4.3 Drug Addiction Therapeutics
12.5 Historic and Forecasted Market Size By Application
12.5.1 Public
12.5.2 Private
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA ADDICTIONS THERAPEUTICS MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Alcohol Addiction Therapeutics
13.4.2 Tobacco Addiction Therapeutics
13.4.3 Drug Addiction Therapeutics
13.5 Historic and Forecasted Market Size By Application
13.5.1 Public
13.5.2 Private
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ADDICTIONS THERAPEUTICS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ADDICTIONS THERAPEUTICS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ADDICTIONS THERAPEUTICS MARKET COMPETITIVE RIVALRY
TABLE 005. ADDICTIONS THERAPEUTICS MARKET THREAT OF NEW ENTRANTS
TABLE 006. ADDICTIONS THERAPEUTICS MARKET THREAT OF SUBSTITUTES
TABLE 007. ADDICTIONS THERAPEUTICS MARKET BY TYPE
TABLE 008. ALCOHOL ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
TABLE 009. TOBACCO ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
TABLE 010. DRUG ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
TABLE 011. ADDICTIONS THERAPEUTICS MARKET BY APPLICATION
TABLE 012. PUBLIC MARKET OVERVIEW (2016-2028)
TABLE 013. PRIVATE MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 016. N ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 019. ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 022. ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 025. ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 028. ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 029. ALKERMES PLC: SNAPSHOT
TABLE 030. ALKERMES PLC: BUSINESS PERFORMANCE
TABLE 031. ALKERMES PLC: PRODUCT PORTFOLIO
TABLE 032. ALKERMES PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. JOHNSON & JOHNSON SERVICES INC.: SNAPSHOT
TABLE 033. JOHNSON & JOHNSON SERVICES INC.: BUSINESS PERFORMANCE
TABLE 034. JOHNSON & JOHNSON SERVICES INC.: PRODUCT PORTFOLIO
TABLE 035. JOHNSON & JOHNSON SERVICES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SNAPSHOT
TABLE 036. TEVA PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS PERFORMANCE
TABLE 037. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 038. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. OPIANT PHARMACEUTICALS INC.: SNAPSHOT
TABLE 039. OPIANT PHARMACEUTICALS INC.: BUSINESS PERFORMANCE
TABLE 040. OPIANT PHARMACEUTICALS INC.: PRODUCT PORTFOLIO
TABLE 041. OPIANT PHARMACEUTICALS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. INDIVIOR PLC: SNAPSHOT
TABLE 042. INDIVIOR PLC: BUSINESS PERFORMANCE
TABLE 043. INDIVIOR PLC: PRODUCT PORTFOLIO
TABLE 044. INDIVIOR PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. NOVARTIS AG: SNAPSHOT
TABLE 045. NOVARTIS AG: BUSINESS PERFORMANCE
TABLE 046. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 047. NOVARTIS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. NOVO NORDISK AS: SNAPSHOT
TABLE 048. NOVO NORDISK AS: BUSINESS PERFORMANCE
TABLE 049. NOVO NORDISK AS: PRODUCT PORTFOLIO
TABLE 050. NOVO NORDISK AS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. AMNEAL PHARMACEUTICALS INC.: SNAPSHOT
TABLE 051. AMNEAL PHARMACEUTICALS INC.: BUSINESS PERFORMANCE
TABLE 052. AMNEAL PHARMACEUTICALS INC.: PRODUCT PORTFOLIO
TABLE 053. AMNEAL PHARMACEUTICALS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. PFIZER INC.: SNAPSHOT
TABLE 054. PFIZER INC.: BUSINESS PERFORMANCE
TABLE 055. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 056. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. MYLAN NV: SNAPSHOT
TABLE 057. MYLAN NV: BUSINESS PERFORMANCE
TABLE 058. MYLAN NV: PRODUCT PORTFOLIO
TABLE 059. MYLAN NV: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ADDICTIONS THERAPEUTICS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ADDICTIONS THERAPEUTICS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ADDICTIONS THERAPEUTICS MARKET COMPETITIVE RIVALRY
TABLE 005. ADDICTIONS THERAPEUTICS MARKET THREAT OF NEW ENTRANTS
TABLE 006. ADDICTIONS THERAPEUTICS MARKET THREAT OF SUBSTITUTES
TABLE 007. ADDICTIONS THERAPEUTICS MARKET BY TYPE
TABLE 008. ALCOHOL ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
TABLE 009. TOBACCO ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
TABLE 010. DRUG ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
TABLE 011. ADDICTIONS THERAPEUTICS MARKET BY APPLICATION
TABLE 012. PUBLIC MARKET OVERVIEW (2016-2028)
TABLE 013. PRIVATE MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 016. N ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 019. ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 022. ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 025. ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA ADDICTIONS THERAPEUTICS MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA ADDICTIONS THERAPEUTICS MARKET, BY APPLICATION (2016-2028)
TABLE 028. ADDICTIONS THERAPEUTICS MARKET, BY COUNTRY (2016-2028)
TABLE 029. ALKERMES PLC: SNAPSHOT
TABLE 030. ALKERMES PLC: BUSINESS PERFORMANCE
TABLE 031. ALKERMES PLC: PRODUCT PORTFOLIO
TABLE 032. ALKERMES PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. JOHNSON & JOHNSON SERVICES INC.: SNAPSHOT
TABLE 033. JOHNSON & JOHNSON SERVICES INC.: BUSINESS PERFORMANCE
TABLE 034. JOHNSON & JOHNSON SERVICES INC.: PRODUCT PORTFOLIO
TABLE 035. JOHNSON & JOHNSON SERVICES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SNAPSHOT
TABLE 036. TEVA PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS PERFORMANCE
TABLE 037. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 038. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. OPIANT PHARMACEUTICALS INC.: SNAPSHOT
TABLE 039. OPIANT PHARMACEUTICALS INC.: BUSINESS PERFORMANCE
TABLE 040. OPIANT PHARMACEUTICALS INC.: PRODUCT PORTFOLIO
TABLE 041. OPIANT PHARMACEUTICALS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. INDIVIOR PLC: SNAPSHOT
TABLE 042. INDIVIOR PLC: BUSINESS PERFORMANCE
TABLE 043. INDIVIOR PLC: PRODUCT PORTFOLIO
TABLE 044. INDIVIOR PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. NOVARTIS AG: SNAPSHOT
TABLE 045. NOVARTIS AG: BUSINESS PERFORMANCE
TABLE 046. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 047. NOVARTIS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. NOVO NORDISK AS: SNAPSHOT
TABLE 048. NOVO NORDISK AS: BUSINESS PERFORMANCE
TABLE 049. NOVO NORDISK AS: PRODUCT PORTFOLIO
TABLE 050. NOVO NORDISK AS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. AMNEAL PHARMACEUTICALS INC.: SNAPSHOT
TABLE 051. AMNEAL PHARMACEUTICALS INC.: BUSINESS PERFORMANCE
TABLE 052. AMNEAL PHARMACEUTICALS INC.: PRODUCT PORTFOLIO
TABLE 053. AMNEAL PHARMACEUTICALS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. PFIZER INC.: SNAPSHOT
TABLE 054. PFIZER INC.: BUSINESS PERFORMANCE
TABLE 055. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 056. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. MYLAN NV: SNAPSHOT
TABLE 057. MYLAN NV: BUSINESS PERFORMANCE
TABLE 058. MYLAN NV: PRODUCT PORTFOLIO
TABLE 059. MYLAN NV: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY TYPE
FIGURE 012. ALCOHOL ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
FIGURE 013. TOBACCO ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
FIGURE 014. DRUG ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
FIGURE 015. ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY APPLICATION
FIGURE 016. PUBLIC MARKET OVERVIEW (2016-2028)
FIGURE 017. PRIVATE MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY TYPE
FIGURE 012. ALCOHOL ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
FIGURE 013. TOBACCO ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
FIGURE 014. DRUG ADDICTION THERAPEUTICS MARKET OVERVIEW (2016-2028)
FIGURE 015. ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY APPLICATION
FIGURE 016. PUBLIC MARKET OVERVIEW (2016-2028)
FIGURE 017. PRIVATE MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA ADDICTIONS THERAPEUTICS MARKET OVERVIEW BY COUNTRY (2016-2028)
